D
Delcath Systems D
D
DCTH
10.085
USD
-0.29
(-2.75%)
مغلق
حجم التداول
18,033
الربح لكل سهم
0
العائد الربحي
-
P/E
336
حجم السوق
356,138,846
الأخبار المقالات
العنوان: Delcath Systems
القطاع: Healthcare
الصناعة: Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.